CD274 and non-small cell lung carcinoma: Results showed that NSCLC patients with a history of smoking treated with ICIs had better overall survival (OS), progression-free survival (PFS), and response rates compared to never-smokers, possibly because tobacco use is related to higher TMB and PD-L1 levels (14–16).